Arachidonic acid metabolites regulate the secretion of atrial natriuretic peptide in cultured rat atrial cardiocytes

B. Kovacic-Milivojevic, H. D. Schultz, D. G. Gardner

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Prostaglandins F(2α) and E2 increase release of immunoreactive (irANP) in primary cultures of rat atrial cardiocytes. This effect is independent of cell density in the cultures and does not appear to operate through a cAMP-dependent mechanism. Studies that probed the PGF(2α) effect with a number of different pharmacological antagonists suggest that it is tied to a calmodulin-dependent step. This latter effect does not appear to be related to increased calcium entry through voltage-gated channels in the plasma membrane nor to mobilization of ryanodine-sensitive intracellular calcium pools. Inhibitors of the lipoxygenase pathway, a second avenue of arachidonate metabolism, resulted in a decrease in irANP release from cultured atrial or ventricular cardiocytes. Leukotriene C4, a lipoxygenase product, had a modest effect to promote irANP release over a 24-h period. However, pretreatment of anesthetized rats with nordihydroguarietic acid, a lipoxygenase inhibitor, had no effect on stretch-dependent release of irANP from the heart in vivo. These findings suggest that the prostaglandins represent the more important group of arachidonate metabolites in regulating irANP release physiologically.

Original languageEnglish (US)
Pages (from-to)1493-1499
Number of pages7
JournalCanadian journal of physiology and pharmacology
Volume69
Issue number10
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Lipoxygenase Inhibitors
Prostaglandins F
Atrial Natriuretic Factor
Arachidonic Acid
Calcium
Ryanodine
Leukotriene C4
Lipoxygenase
Calmodulin
Dinoprostone
Prostaglandins
Cell Count
Cell Membrane
Pharmacology
Acids

Keywords

  • ANP secretion
  • cardiovascular homeostasis
  • leukotrienes
  • prostaglandins

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Arachidonic acid metabolites regulate the secretion of atrial natriuretic peptide in cultured rat atrial cardiocytes. / Kovacic-Milivojevic, B.; Schultz, H. D.; Gardner, D. G.

In: Canadian journal of physiology and pharmacology, Vol. 69, No. 10, 01.01.1991, p. 1493-1499.

Research output: Contribution to journalArticle

@article{2807a5ecfb5b467d89d8f3f91a129267,
title = "Arachidonic acid metabolites regulate the secretion of atrial natriuretic peptide in cultured rat atrial cardiocytes",
abstract = "Prostaglandins F(2α) and E2 increase release of immunoreactive (irANP) in primary cultures of rat atrial cardiocytes. This effect is independent of cell density in the cultures and does not appear to operate through a cAMP-dependent mechanism. Studies that probed the PGF(2α) effect with a number of different pharmacological antagonists suggest that it is tied to a calmodulin-dependent step. This latter effect does not appear to be related to increased calcium entry through voltage-gated channels in the plasma membrane nor to mobilization of ryanodine-sensitive intracellular calcium pools. Inhibitors of the lipoxygenase pathway, a second avenue of arachidonate metabolism, resulted in a decrease in irANP release from cultured atrial or ventricular cardiocytes. Leukotriene C4, a lipoxygenase product, had a modest effect to promote irANP release over a 24-h period. However, pretreatment of anesthetized rats with nordihydroguarietic acid, a lipoxygenase inhibitor, had no effect on stretch-dependent release of irANP from the heart in vivo. These findings suggest that the prostaglandins represent the more important group of arachidonate metabolites in regulating irANP release physiologically.",
keywords = "ANP secretion, cardiovascular homeostasis, leukotrienes, prostaglandins",
author = "B. Kovacic-Milivojevic and Schultz, {H. D.} and Gardner, {D. G.}",
year = "1991",
month = "1",
day = "1",
doi = "10.1139/y91-224",
language = "English (US)",
volume = "69",
pages = "1493--1499",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "10",

}

TY - JOUR

T1 - Arachidonic acid metabolites regulate the secretion of atrial natriuretic peptide in cultured rat atrial cardiocytes

AU - Kovacic-Milivojevic, B.

AU - Schultz, H. D.

AU - Gardner, D. G.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Prostaglandins F(2α) and E2 increase release of immunoreactive (irANP) in primary cultures of rat atrial cardiocytes. This effect is independent of cell density in the cultures and does not appear to operate through a cAMP-dependent mechanism. Studies that probed the PGF(2α) effect with a number of different pharmacological antagonists suggest that it is tied to a calmodulin-dependent step. This latter effect does not appear to be related to increased calcium entry through voltage-gated channels in the plasma membrane nor to mobilization of ryanodine-sensitive intracellular calcium pools. Inhibitors of the lipoxygenase pathway, a second avenue of arachidonate metabolism, resulted in a decrease in irANP release from cultured atrial or ventricular cardiocytes. Leukotriene C4, a lipoxygenase product, had a modest effect to promote irANP release over a 24-h period. However, pretreatment of anesthetized rats with nordihydroguarietic acid, a lipoxygenase inhibitor, had no effect on stretch-dependent release of irANP from the heart in vivo. These findings suggest that the prostaglandins represent the more important group of arachidonate metabolites in regulating irANP release physiologically.

AB - Prostaglandins F(2α) and E2 increase release of immunoreactive (irANP) in primary cultures of rat atrial cardiocytes. This effect is independent of cell density in the cultures and does not appear to operate through a cAMP-dependent mechanism. Studies that probed the PGF(2α) effect with a number of different pharmacological antagonists suggest that it is tied to a calmodulin-dependent step. This latter effect does not appear to be related to increased calcium entry through voltage-gated channels in the plasma membrane nor to mobilization of ryanodine-sensitive intracellular calcium pools. Inhibitors of the lipoxygenase pathway, a second avenue of arachidonate metabolism, resulted in a decrease in irANP release from cultured atrial or ventricular cardiocytes. Leukotriene C4, a lipoxygenase product, had a modest effect to promote irANP release over a 24-h period. However, pretreatment of anesthetized rats with nordihydroguarietic acid, a lipoxygenase inhibitor, had no effect on stretch-dependent release of irANP from the heart in vivo. These findings suggest that the prostaglandins represent the more important group of arachidonate metabolites in regulating irANP release physiologically.

KW - ANP secretion

KW - cardiovascular homeostasis

KW - leukotrienes

KW - prostaglandins

UR - http://www.scopus.com/inward/record.url?scp=0026346917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026346917&partnerID=8YFLogxK

U2 - 10.1139/y91-224

DO - 10.1139/y91-224

M3 - Article

C2 - 1723348

AN - SCOPUS:0026346917

VL - 69

SP - 1493

EP - 1499

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 10

ER -